Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

The Offering is structured as units priced at $0.06 each, with each unit consisting of one common share and one warrant to purchase a common share. Each warrant entitles the holder to purchase one additional common share at a price of $0.10 per share, exercisable for a period of 24 months. Rakovina retains the right to accelerate the warrant exercise period if the 20-day volume-weighted average price of its shares exceeds $0.30. Read More

Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million